Year: 2006
Type: article
Abstract: As the Leadership of the American Society for Bone and Mineral Research and the former and current Editors‐in‐Chief of the Journal of Bone and Mineral Research, we acknowledge the importance of interactions between the pharmaceutical and device industries and the faculty of academic research institutions and the benefits to the advancement of science and human health that can flow from the research which results from these relationships. At its best, this interaction brings together the intellectual strength of the partners in these relationships and supports it with the organizational and financial resources of industry. As a result, a growing role of industry support of biomedical research has become a vital aspect of medical and health research in the 21st century. The representatives of academia and industry share as an important objective of their efforts, performance of effective scientific investigations and development of better and safer treatments for major diseases and conditions that detract from human health, quality of life, and survival. However, these interactions also encompass inevitable differences in additional objectives, sometimes leading to powerful financial pressures, which can result in real or potential conflicts of interest.
DOI: 10.1359/jbmr.060113
Institution: American Society for Bone and Mineral Research
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1998305931